Stock Information
Urogen Pharma Ltd (URGN)
Ticker Symbol: URGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,148.14 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.98
Revenue (TTM): $3.75 M
Dividend Yield: N/A
ROE: -204.47%
Latest News
-
Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity?
Wed, Sep 23, 2026 7:32 PM
-
Is UroGen’s (URGN) Commercial Engine Strong Enough To Fund Its Pipeline Ambitions?
Wed, Sep 23, 2026 1:13 PM
Key Financials
Financial data not available
